Refractory Endometrial Endometrioid Adenocarcinoma (DBCOND0131052)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT04719273	Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer	Anastrozole Benzalkonium Onapristone	treatment	2	active_not_recruiting
NCT03008408	A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma	Everolimus Letrozole Ribociclib	treatment	2	active_not_recruiting